Akash Tewari
Stock Analyst at Jefferies
(3.69)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
IONS Ionis Pharmaceutical... | Maintains: Strong Buy | 83 96 | 63.06 | 52.24% | 2 | Sep 2, 2025 | |
REGN Regeneron Pharmaceut... | Maintains: Strong Buy | 813 831 | 566.08 | 46.8% | 5 | Aug 27, 2025 | |
CBIO Crescent Biopharma | Initiates Coverage On: Buy | 26 | n/a | n/a | 1 | Aug 25, 2025 | |
ARVN Arvinas | Downgrades: Hold | 52 10 | 8.02 | 24.69% | 3 | May 2, 2025 | |
BMY Bristol-Myers Squibb | Maintains: Buy | 70 68 | 47.77 | 42.35% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 95 | 54.47 | 74.41% | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 96 150 | 101.62 | 47.61% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 11 16 | 4.11 | 289.29% | 3 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 177 189 | 143.06 | 32.11% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 80 | 25.72 | 211.04% | 2 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 994 1015 | 757.66 | 33.97% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 42 50 | 27.19 | 83.89% | 5 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 37 75 | 37.92 | 97.78% | 4 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 31 | 16.32 | 89.95% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 12 | 2.27 | 428.63% | 2 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 38 39 | 24.8 | 57.26% | 2 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 49 18 | 8.57 | 110.04% | 2 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 497 513 | 767.64 | -33.17% | 2 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 7.56 | 138.1% | 1 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 125 | 84.89 | 47.25% | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 8 11 | 15.82 | -30.47% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 30 4 | 5.38 | -33.09% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 17 | 1.59 | 969.18% | 1 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 6 4 | 2.34 | 36.75% | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 68 69 | n/a | n/a | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 75 | 52.33 | 43.32% | 2 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 151 | 431.69 | -65.02% | 1 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 28 | 38.17 | -26.64% | 2 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 180 | n/a | n/a | 2 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 107 | 116.3 | -8% | 1 | Mar 12, 2021 |